Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Eva Recio"'
Autor:
Juan Macías, Luis F López-Cortés, Francisco Téllez, Eva Recio, Guillermo Ojeda-Burgos, Maria José Ríos, Antonio Rivero-Juárez, Marcial Delgado, Rivas-Jeremías, Juan A Pineda
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0143492 (2015)
Nitazoxanide (NTZ) plus pegylated interferon and ribavirin (Peg-IFN/RBV) improved the sustained virological response (SVR) achieved with Peg-IFN/RBV in hepatitis C virus genotype 4 (HCV-4)-monoinfected patients. There are no data currently on the eff
Externí odkaz:
https://doaj.org/article/a117626c031d44a1b93460456223b611
Autor:
C. García, Natalia Chueca, Juan Macías, Juan A. Pineda, Juan Pasquau, Dolores Merino, G. Ojeda, P Jiménez, Eva Recio, Manuel Márquez, P Bancalero, Leopoldo Muñoz
Publikováno v:
HIV Medicine. 15:417-424
Objectives Nucleoside reverse transcriptase inhibitor (NRTI)-sparing regimens may be needed in patients with NRTI toxicity. Maraviroc (MVC) plus ritonavir-boosted darunavir (DRV-r) or atazanavir is associated with slightly lower response rates than t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6215c839f4ea79420d0591e4074a24d
https://doi.org/10.1111/hiv.12129
https://doi.org/10.1111/hiv.12129
Autor:
Elisabet Pérez-Navarro, Celia Cifuentes, Adoración Valiente, Juan A. Pineda, María Mancebo-Hernández, Eva Recio, Patricia Monje-Agudo
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 33:110-112
Resumen Introduccion La prevalencia de hepatitis C es menor en los nuevos casos de pacientes infectados por VIH en Espana. El uso creciente del tratamiento frente al VHC podria haber cambiado la distribucion genotipica del VHC. El objetivo de este es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4e2771af4b7881e36fad1a7b293c89d
https://doi.org/10.1016/j.eimc.2014.05.010
https://doi.org/10.1016/j.eimc.2014.05.010
Autor:
Luis Miguel Real, Juan Macías, María Mancebo, Karin Neukam, Elisabet Pérez, Juan A. Pineda, Eva Recio, Patricia Monje-Agudo, José A. Mira, Nicolás Merchante
Publikováno v:
European journal of gastroenterologyhepatology. 28(11)
BACKGROUND The drug options and strategies for treatment against hepatitis C virus (HCV) infection have changed considerably in the last few years. The aim of this study was to compare the changes in the proportion of nonresponders and patients who a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e382c33378b5e959a02420018db15c7d
https://pubmed.ncbi.nlm.nih.gov/27415157
https://pubmed.ncbi.nlm.nih.gov/27415157
Autor:
Francisco Téllez, Marcial Delgado, Rivas Jeremías, Eva Recio, Juan A. Pineda, Antonio Rivero-Juárez, Luis F. López-Cortés, Juan Macías, M.J. Ríos, Guillermo Ojeda-Burgos
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 12, p e0143492 (2015)
PLoS ONE, Vol 10, Iss 12, p e0143492 (2015)
Journal Article; Research Support, Non-U.S. Gov't; TRIAL REGISTRATION ClinicalTrials.gov NCT01529073. BACKGROUND Nitazoxanide (NTZ) plus pegylated interferon and ribavirin (Peg-IFN/RBV) improved the sustained virological response (SVR) achieved with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6ba525e586c017af368a7f147960bee
https://hdl.handle.net/10668/2345
https://hdl.handle.net/10668/2345
Autor:
Karin Neukam, José A. Mira, Carmen Almeida, C. Lopez, Angela Camacho, Juan Macías, Eva Recio, Julián de la Torre, Antonio Rivero, Juan A. Pineda
Publikováno v:
European Journal of Gastroenterology & Hepatology. 22:801-807
OBJECTIVES Although the reproducibility of transient elastometry (TE) in hepatitis C virus (HCV)-monoinfected patients seems to be high, this may not be the case in HIV/HCV-coinfected patients because of different degrees of steatosis and/or inflamma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b4531fbaacb17ac5c190877eefa0ace
https://doi.org/10.1097/meg.0b013e328331a5d0
https://doi.org/10.1097/meg.0b013e328331a5d0
Autor:
Juan A. Pineda, Juan Macías, Luis F. López-Cortés, Eugenia Vispo, Mercedes González, Victor de Ledinghen, Antonio Rivero, Pablo Barreiro, Eva Recio, Dolores Merino, Carmen Quereda, M. José Ríos
Publikováno v:
Journal of Hepatology. 49:916-922
Background/Aims Transient elastometry (TE) is accurate for detecting cirrhosis ( F =4) in human immunodeficiency virus (HIV)/hepatitis C virus (HCV) co-infected patients. However, this procedure is less precise to differentiate mild ( F ⩽1) from mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a806f40cdb5e64d18bfbc8f67931f5cc
https://doi.org/10.1016/j.jhep.2008.07.031
https://doi.org/10.1016/j.jhep.2008.07.031
Autor:
Antonio Rivero, Antonio Caruz, Ana Gordon, Luis Miguel Real, Francisco J. Márquez, Antonio Rivero-Juárez, Mario Frias, Eva Recio, Loreto Martinez-Dueñas, Angela Camacho, Juan A. Pineda
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 34(11)
Hepatitis C virus (HCV) viral persistence in patients with spontaneous viral clearance is controversial. Several studies have shown HCV-RNA in peripheral blood mononuclear cells (PBMCs) and/or liver tissue among patients who have cleared the virus sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::657f44511c9334b2dd201a2cb27893dd
https://pubmed.ncbi.nlm.nih.gov/26254560
https://pubmed.ncbi.nlm.nih.gov/26254560
Autor:
Celia Cifuentes, Antonio Rivero-Juárez, Manuel Parra-Sánchez, Karin Neukam, Eva Recio, José A. Mira, Juan A. Pineda, Carmen Almeida, Juan Macías
Publikováno v:
European journal of gastroenterologyhepatology. 25(8)
Background The combination of transient elastometry with a controlled attenuation parameter (CAP) is available to evaluate hepatic steatosis (HS) along with liver stiffness. Aims To assess the concordance of CAP measurements between two independent o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df6d49606f9c4968246dc835f32eecdc
https://pubmed.ncbi.nlm.nih.gov/23459105
https://pubmed.ncbi.nlm.nih.gov/23459105
Autor:
Silvia García-Rey, María del Mar González, Pablo Labarga, Federico A. Di Lello, Juan A. Pineda, Juan Macías, Vicente Soriano, Zulema Plaza, Celia Cifuentes, Manuel Parra-Sánchez, Eva Recio, Eva Poveda
Publikováno v:
Antiviral Research; Vol 95
To assess the impact of antiretroviral treatment (ART), including nucleoside analogues retrotranscriptase inhibitors (NRTIs), on the mutation rate of hepatitis C virus (HCV) NS5B polymerase and on the ratio of substitution at synonymous and nonsynony
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7815deb03d88cd68c9fd9e10b15227c7
https://pubmed.ncbi.nlm.nih.gov/22683722
https://pubmed.ncbi.nlm.nih.gov/22683722